Cancer risk falls in some HAART users.
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D018791:CD4 Lymphocyte Count; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000139:chemically induced*